Pantoprazole
DrugBank ID: DB00213
Summary
| Metric | Value |
|---|---|
| Total Predictions | 51 |
| KG+DL (Dual Validated) | 7 |
| DL Only | 43 |
| KG Only | 1 |
Predictions
| Indication | Score | Source |
|---|---|---|
| peptic esophagitis | 0.9987 | KG+DL |
| multiple endocrine neoplasia | 0.9981 | KG+DL |
| active peptic ulcer disease | 0.9969 | DL |
| gastrojejunal ulcer | 0.9963 | DL |
| peptic ulcer perforation | 0.9963 | DL |
| duodenogastric reflux | 0.9927 | DL |
| esophagitis (disease) | 0.9924 | KG+DL |
| duodenal obstruction | 0.9921 | DL |
| duodenal ulcer (disease) | 0.9918 | DL |
| acne (disease) | 0.9835 | DL |
| gastric ulcer (disease) | 0.9805 | DL |
| Zollinger-Ellison syndrome | 0.9792 | KG+DL |
| Smouldering systemic mastocytosis | 0.9738 | DL |
| gastrin secretion abnormality | 0.9677 | KG+DL |
| lymphoadenopathic mastocytosis with eosinophilia | 0.9660 | DL |
| gastroduodenitis | 0.9647 | DL |
| peptic ulcer disease | 0.9312 | KG+DL |
| systemic mastocytosis | 0.9263 | DL |
| abnormality of glucagon secretion | 0.8485 | DL |
| leather-bottle stomach | 0.8477 | DL |
| duodenitis | 0.8320 | DL |
| hyperinsulinism (disease) | 0.7563 | KG+DL |
| hyperglycemia | 0.6601 | DL |
| Wiskott-Aldrich syndrome 2 | 0.6233 | DL |
| FADD-related immunodeficiency | 0.6214 | DL |
| secondary short bowel syndrome | 0.6145 | DL |
| oculootodental syndrome | 0.6077 | DL |
| pancreas disease | 0.5966 | DL |
| cholangiocarcinoma, susceptibility to | 0.5928 | DL |
| hernia, anterior diaphragmatic | 0.5920 | DL |
| thiopurine immunosuppressant-induced pancreatitis | 0.5906 | DL |
| diphtheritic myocarditis | 0.5891 | DL |
| eosinophilic esophagitis | 0.5807 | DL |
| sudden arrhythmia death syndrome | 0.5785 | DL |
| baylisascariasis | 0.5769 | DL |
| lymphopenic hypergammaglobulinemia, antibody deficiency, autoimmune hemolytic anemia, and glomerulonephritis | 0.5758 | DL |
| afferent loop syndrome | 0.5756 | DL |
| trichostrongylosis | 0.5744 | DL |
| scleral staphyloma (disease) | 0.5628 | DL |
| myopathy due to calsequestrin and SERCA1 protein overload | 0.5621 | DL |
| intestinal impaction | 0.5599 | DL |
| arteriosclerosis obliterans | 0.5592 | DL |
| congenital aortic valve stenosis | 0.5586 | DL |
| radiation proctitis | 0.5573 | DL |
| pyuria (disease) | 0.5560 | DL |
| entropion (disease) | 0.5543 | DL |
| astigmatism (disease) | 0.5535 | DL |
| non-syndromic diaphragmatic or abdominal wall malformation | 0.5531 | DL |
| giant neutrophil leukocytes | 0.5522 | DL |
| Coronavinae infectious disease | 0.5521 | DL |
Showing top 50 of 51 predictions.
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.